Small Pharma Inc DMTTF

Primary Symbol: V.DMT

Healthcare

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.

TSXV:DMT - Post by User

Small Pharma Inc > Peter Rands buys 139,400 shares of Small Pharma Inc.

<< Previous

Bullboard Posts

Next >>

Comment by GillRipperon Sep 06, 2022 7:43pm

65 Views

Post# 34945267

RE:Peter Rands buys 139,400 shares of Small Pharma Inc.

Rand's buys paper all the way up to .40.

Oh yeah.....yup.

Markets look like they are on life support, but this little company is bucking the trend.

Could the wind temporaily get taken out of our sails during a market washout-full court press ... of course.

But not withstanding an apocaliptic scenario unfolding....big Pharma buys small Pharma is the end game here IMHO.

Timeline.... "unknow"

Kind Regards To All

Fish Rippah.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project